Natixis Partners Iberia advised the private equity firm 3i on the acquisition of Panreac Química, a portfolio company of the private equity firm Bridgepoint, for €48,5m in cash.
PANREAC is a leading Spanish manufacturer and supplier of fine chemicals for laboratory testing and production processes. 3i’s investment will enable the company to maintain its market leading brand in analytical reagents in Spain, continue to grow organically through product diversification, and implement plans for international expansion, particularly in Germany, France and Italy.